Andrew Jacobs
Andrew Jacobs is a reporter for The New York Times with a background in health and science. He focuses on how healthcare policy, politics, and corporate interests affect people's lives. He has covered a wide range of beats during his nearly three decades at The Times including New Jersey politics, the American South, New York City nightlife, policing and the criminal justice system. Andrew has also reported from nearly two dozen countries such as Brazil, Kenya, India, Israel and China. He is part of two reporting teams at The Times that won Pulitzer Prizes including a 2002 award for coverage of the 9/11 terrorist attacks.
96%
The Daily's Verdict
This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.
Bias
100%
Examples:
- Andrew Jacobs appears to maintain a neutral point of view in his reporting.
Conflicts of Interest
100%
Examples:
- No conflicts of interest have been identified.
Contradictions
50%
Examples:
- In one article, Andrew mentions potential benefits of psychedelic medicine for mental health disorders while in another he briefly discusses a study that could potentially lead to such treatments.
- In two articles, Andrew reports on the effects of psilocybin on the brain but does not contradict himself.
Deceptions
100%
Examples:
- No deceptive practices have been identified.
Recent Articles
New Study Reveals Psilocybin's Impact on Brain, Temporarily Resets Neurons and Disrupts Communication
Broke On: Wednesday, 17 July 2024Researchers at Washington University and Harvard Schools discovered that psilocybin, the compound in magic mushrooms, significantly alters brain activity. The studies showed temporary resetting of neurons controlling time and self, disrupting communication between default mode network and anterior hippocampus for weeks. These findings suggest potential therapeutic effects on neurological conditions like PTSD and depression. Psilocybin's Lasting Impact on Brain Activity: A Week-Long Disruption of the Default Mode Network
Broke On: Wednesday, 17 July 2024In a groundbreaking study, researchers at Washington University School of Medicine found that psilocybin, a psychedelic compound in magic mushrooms, disrupted brain activity in the default mode network for weeks after consumption. This loss of synchrony may explain altered perceptions and potential therapeutic benefits for conditions like depression and PTSD.